← The Wire
GALTNasdaq
GALECTIN THERAPEUTICS INC
Pharmaceutical Preparations · NV · CIK 1133416
Develops carbohydrate-based therapies targeting galectin proteins for fibrotic diseases and cancer
$176M
Market cap
$4.97
Last close
-0.4%
1D
+77.5%
5D
1.9M
Volume
Price · last 39 sessions+117.0%
May 4L $2.08 · H $4.99Jun 29
335
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
8-KReg FD DisclosureJun 23, 20268-KResults of OperationsMay 15, 202610-Q10-QMay 15, 20268-KResults of OperationsMar 31, 202610-K10-KMar 31, 20268-KExecutive ChangeMar 17, 20268-KExecutive ChangeJan 21, 20268-KExecutive ChangeJan 12, 20268-KMaterial AgreementDec 19, 20258-KShareholder VoteDec 8, 20258-KReg FD DisclosureDec 3, 20258-KResults of OperationsNov 14, 202510-Q10-QNov 14, 20258-KReg FD DisclosureNov 10, 2025DEFA14ADEFA14AOct 22, 2025DEF 14ADEF 14AOct 22, 20258-KReg FD DisclosureSep 8, 20258-KResults of OperationsAug 14, 202510-Q10-QAug 14, 20258-KExecutive Change · Material AgreementJul 9, 20258-KReg FD DisclosureJun 16, 20258-KResults of OperationsMay 15, 202510-Q10-QMay 15, 20258-KReg FD Disclosure · Company UpdateMay 12, 20258-KResults of OperationsMar 31, 202510-K10-KMar 31, 20258-KReg FD DisclosureMar 5, 20258-KCompany UpdateFeb 18, 20258-KShareholder VoteJan 28, 20258-KReg FD DisclosureJan 23, 20258-KReg FD DisclosureJan 13, 20258-KCompany UpdateDec 20, 2024DEFA14ADEFA14ADec 3, 2024DEF 14ADEF 14ADec 3, 20248-KReg FD DisclosureNov 14, 20248-KResults of OperationsNov 14, 202410-Q10-QNov 14, 20248-KReg FD DisclosureSep 9, 20248-KResults of OperationsAug 13, 202410-Q10-QAug 13, 20248-KExecutive ChangeAug 1, 20248-KResults of OperationsMay 15, 202410-Q10-QMay 15, 20248-KResults of OperationsMar 29, 202410-K10-KMar 29, 20248-KShareholder VoteDec 11, 20238-KReg FD DisclosureDec 7, 20238-K/AResults of OperationsNov 13, 20238-KResults of OperationsNov 13, 202310-Q10-QNov 13, 2023DEFA14AFORM DEFA14AOct 6, 2023DEF 14ADEF 14AOct 6, 20238-KResults of OperationsAug 14, 202310-Q10-QAug 14, 20238-KResults of OperationsMay 15, 202310-Q10-QMay 15, 20238-KResults of OperationsMar 30, 202310-K10-KMar 30, 20238-KCompany UpdateMar 2, 20238-KCompany UpdateJan 5, 20238-KShareholder VoteDec 6, 20228-KReg FD DisclosureDec 1, 20228-KResults of OperationsNov 14, 202210-Q10-QNov 14, 2022DEFA14ADEFA14AOct 17, 2022DEF 14ADEF 14AOct 17, 20228-KCompany UpdateOct 12, 20228-KCompany UpdateOct 6, 20228-KResults of OperationsAug 15, 202210-Q10-QAug 15, 20228-KExecutive Change · Material AgreementJul 26, 20228-KResults of OperationsMay 16, 202210-Q10-QMay 16, 20228-KCompany UpdateApr 14, 20228-KResults of OperationsMar 31, 202210-K10-KMar 31, 20228-KMaterial Agreement · New Debt / ObligationDec 21, 20218-KShareholder VoteDec 7, 20218-KReg FD DisclosureDec 3, 20218-KResults of OperationsNov 15, 2021
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Feb 6, 2026: 2 insiders bought $65K · 6 sold $5.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 6, 2026 | Eldred KaryDirector | Buy | 300 | $2.70 | $810 |
| Jan 6, 2026 | Lewis JoelPresident and CEO | Sell | 37,698 | $3.58 | $135K |
| Jan 6, 2026 | Jamil KhurramChief Medical Officer | Sell | 21,446 | $3.65 | $78K |
| Jan 6, 2026 | Callicutt Jack WChief Financial Officer | Sell | 20,354 | $3.67 | $75K |
| Jan 5, 2026 | Lewis JoelPresident and CEO | Sell | 27,731 | $3.91 | $108K |
| Jan 5, 2026 | Callicutt Jack WChief Financial Officer | Sell | 25,732 | $3.90 | $100K |
| Jan 5, 2026 | Jamil KhurramChief Medical Officer | Sell | 25,499 | $3.90 | $99K |
| Jan 2, 2026 | Lewis JoelPresident and CEO | Sell | 18,571 | $4.20 | $78K |
| Jan 2, 2026 | Callicutt Jack WChief Financial Officer | Sell | 13,914 | $4.20 | $58K |
| Jan 2, 2026 | Jamil KhurramChief Medical Officer | Sell | 13,055 | $4.20 | $55K |
| Dec 31, 2025 | Jamil KhurramChief Medical Officer | Sell | 8,125 | $4.07 | $33K |
| Dec 23, 2025 | Freeman Kevin DDirector | Buy | 5,500 | $3.55 | $20K |
| Dec 23, 2025 | Freeman Kevin DDirector | Buy | 5,500 | $3.55 | $20K |
| Dec 23, 2025 | Freeman Kevin DDirector | Buy | 5,500 | $3.55 | $20K |
| Dec 23, 2025 | Eldred KaryDirector | Buy | 700 | $3.73 | $3K |
| Dec 23, 2025 | Eldred KaryDirector | Buy | 700 | $3.73 | $3K |
| Dec 17, 2025 | Shlevin Harold H.Director | Sell | 19,793 | $7.04 | $139K |
| Dec 17, 2025 | Jamil KhurramChief Medical Officer | Sell | 8,500 | $7.04 | $60K |
| Dec 17, 2025 | Lewis JoelPresident and CEO | Sell | 7,829 | $7.06 | $55K |
| Dec 17, 2025 | Jamil KhurramChief Medical Officer | Sell | 6,463 | $7.04 | $45K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance